NovoCure Limited - Ordinary Shares (NQ:NVCR)

14.98 +0.04 (+0.27%)

Delayed Quote Updated: 2:39 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

21 22 Next >

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVCR

June 30, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

NovoCure Investors: August 18, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

June 29, 2023

From Lieff Cabraser Heimann & Bernstein, LLP

Via Business Wire

NOVOCURE LIMITED (NASDAQ: NVCR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NovoCure Limited

June 28, 2023

Did you lose money on investments in NovoCure Limited? If so, please visit NovoCure Limited Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to...

From Bernstein Liebhard LLP

Via GlobeNewswire

NovoCure Limited (NVCR) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against NovoCure Limited

June 27, 2023

From Robbins LLP

Via Business Wire

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NovoCure Limited (NVCR)

June 27, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

ROSEN, A LEADING LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCR

June 26, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

NVCR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that NovoCure Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

June 26, 2023

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NovoCure Limited (NVCR)

June 26, 2023

From Law Offices of Howard G. Smith

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against TriplePoint, NovoCure, and UP Fintech and Encourages Investors to Contact the Firm

June 25, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, SKILLED INVESTOR COUNSEL, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCR

June 25, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Calling All Investors in NovoCure Limited (NVCR): New Lawsuit Lead Plaintiff Deadline is August 18, 2023 - Contact Bronstein, Gewirtz & Grossman, LLC Today

June 23, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of NovoCure Limited (NVCR) Investors

June 23, 2023

From Kirby McInerney LLP

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of NovoCure Limited (NVCR) Investors

June 22, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of NovoCure Limited (NVCR) Investors

June 22, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

Calling All Investors in NovoCure Limited (NVCR): New Lawsuit Lead Plaintiff Deadline Is August 18, 2023 - Contact Bronstein, Gewirtz & Grossman, LLC Today

June 22, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of NovoCure Limited (NVCR) Investors

June 21, 2023

From Law Offices of Howard G. Smith

Via Business Wire

EQUITY ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – NVCR

June 21, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

Scott+Scott Attorneys at Law LLP Reminds Investors That a Securities Class Action Has Been Filed Against NovoCure Limited (NASDAQ: NVCR); Lead Plaintiff Deadline is August 18, 2023

June 21, 2023

From Scott+Scott Attorneys at Law LLP

Via Business Wire

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against NovoCure Limited (NVCR)

June 20, 2023

From Robbins LLP

Via Business Wire

NOVOCURE SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NovoCure Limited - NVCR

June 20, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

NVCR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that NovoCure Limited Investors with Substantial Losses Have Opportunity to Lead the NovoCure Class Action Lawsuit

June 20, 2023

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

NOVOCURE LIMITED (NASDAQ: NVCR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against NovoCure Limited

June 20, 2023

From Bernstein Liebhard LLP

Via GlobeNewswire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

June 20, 2023

From The Schall Law Firm

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

June 19, 2023

From The Schall Law Firm

Via Business Wire

NOVOCURE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against NovoCure Limited and Encourages Investors to Contact the Firm

June 19, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of NovoCure Limited (NVCR) on Behalf of Investors

June 16, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Announces Investigation into NovoCure Limited (NVCR)

June 16, 2023

From Scott+Scott Attorneys at Law LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of NovoCure Limited (NVCR) on Behalf of Investors

June 15, 2023

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of NovoCure Limited (NVCR) on Behalf of Investors

June 15, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

3 Small-Cap Drug Stocks to Watch as Their Clinical Trials End Soon ↗

June 12, 2023

These three small cap drug companies could become gold or lead depending on the outcomes of their clinical trials.

Via InvestorPlace

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.